These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3463178)

  • 1. Pharmacokinetics of metamizol metabolites.
    Levy M
    Agents Actions Suppl; 1986; 19():199-204. PubMed ID: 3463178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of the main metabolites of dipyrone by high-pressure liquid chromatography.
    Damm D
    Arzneimittelforschung; 1989 Nov; 39(11):1415-7. PubMed ID: 2619775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metamizol--acute overdose with suicidal intent].
    Wolhoff H; Altrogge G; Pola W; Sistovaris N
    Dtsch Med Wochenschr; 1983 Nov; 108(46):1761-4. PubMed ID: 6641523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elimination of caffeine and metamizol in in vivo characterization of cytochrome P-450 dependent biotransformation reactions in aged humans].
    Ortweiler W; Stein G; Simon HU; Siegert C; Splinter FK; Traeger A
    Pharmazie; 1985 Nov; 40(11):787-90. PubMed ID: 4095131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between saliva levels of metamizol metabolites, bioavailability and analgesic efficacy.
    Rohdewald P; Drehsen G; Milsmann E; Derendorf H
    Arzneimittelforschung; 1983; 33(7):985-8. PubMed ID: 6684934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent pharmacokinetics of metabolites of dipyrone in saliva.
    Neddermann E; Rohdewald P
    Eur J Drug Metab Pharmacokinet; 1988; 13(2):105-11. PubMed ID: 3208789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and biotransformation of pyrazolinones.
    Roth HJ
    Agents Actions Suppl; 1986; 19():205-21. PubMed ID: 3463179
    [No Abstract]   [Full Text] [Related]  

  • 8. High-performance liquid chromatographic analysis of dipyrone metabolites to study their formation in human liver microsomes.
    Geisslinger G; Böcker R; Levy M
    Pharm Res; 1996 Aug; 13(8):1272-5. PubMed ID: 8865325
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of cimetidine on the pharmacokinetics of the metabolites of metamizol.
    Bacracheva N; Tyutyulkova N; Drenska A; Gorantcheva J; Schinzel S; Scholl T; Stoinov A; Tchakarski I; Tentcheva J; Vlahov V
    Int J Clin Pharmacol Ther; 1997 Jul; 35(7):275-81. PubMed ID: 9247840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation and excretion of dipyrone metabolites in man.
    Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1992; 42(2):187-91. PubMed ID: 1618251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and pharmacological effects of dipyrone and its metabolites in model systems related to arachidonic acid cascade.
    Weithmann KU; Alpermann HG
    Arzneimittelforschung; 1985; 35(6):947-52. PubMed ID: 3927930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies on the effect of long term progestagen administration on the elimination of noramidopyrine methanesulfonate (Analgin)].
    Voigt R; Nöschel H; Müller B
    Zentralbl Gynakol; 1977; 99(3):161-4. PubMed ID: 899364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium.
    Vlahov V; Badian M; Verho M; Bacracheva N
    Eur J Clin Pharmacol; 1990; 38(1):61-5. PubMed ID: 2328750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of dipyrone in man; role of the administration route.
    Asmardi G; Jamali F
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):121-5. PubMed ID: 4043141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of various liver diseases on the activity of 2 subtypes of cytochrome P-450].
    Balogh A; Simon HJ; Reinhardt M; Splinter FK; Traeger A
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(1):1-13. PubMed ID: 3582233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of saliva samples for the estimation of dipyrone metabolites pharmacokinetics.
    Caraco Y; Zylber-Katz E; Granit L; Levy M
    Arzneimittelforschung; 1993 Nov; 43(11):1204-8. PubMed ID: 8292065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excretion of dipyrone metabolites in human breast milk.
    Zylber-Katz E; Linder N; Granit L; Levy M
    Eur J Clin Pharmacol; 1986; 30(3):359-61. PubMed ID: 3732376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of measuring the blood flow in the gastric mucosa of dogs by the 99mTc-4-methylaminophenazone clearance method].
    Döbrönte Z; Láng J; Sági I; Varró
    Fiziol Zh SSSR Im I M Sechenova; 1982 May; 68(5):660-6. PubMed ID: 7095200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma protein binding of dipyrone metabolites in man.
    Zylber-Katz E; Granit L; Levy M
    Eur J Clin Pharmacol; 1985; 29(1):67-71. PubMed ID: 4054207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of oxalic acid derivatives as new metabolites of metamizol (dipyrone) in incubated hen's egg and human.
    Wessel JC; Matyja M; Neugebauer M; Kiefer H; Daldrup T; Tarbah FA; Weber H
    Eur J Pharm Sci; 2006 May; 28(1-2):15-25. PubMed ID: 16417995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.